Evidence map›Paper›PMID 41414674›Full record

ArticleNucleic acids research2025

The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner.

Chuan Li, Yuan Ma, Luisa P Mori, Huiming Yang, Yi Wang, Thomas T Venables, Ronald Bronson, Ryan R Milione, Mathew E Pipkin, Susana T Valente

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chuan LiDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Yuan MaDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Luisa P MoriDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Huiming YangDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Yi WangDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Thomas T VenablesDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Ronald BronsonDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Ryan R MilioneDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Mathew E PipkinDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Susana T ValenteDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.ORCID 0000-0002-7854-7554

Funding

HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
Mode of action of a new Tat HIV-1 inhibitorR01AI097012 · NIAID · UNIVERSITY OF FLORIDA · PI VALENTE, SUSANA T · 2012 to 2022
$7.5M
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque modelR01AI167732 · NIAID · UNIVERSITY OF FLORIDA · PI David T Evans, Susana T Valente · 2021 to 2026
$4.3M
Identification and characterization of chromatin regulators of HIV-1 latencyR61AI140439 · NIAID · SCRIPPS FLORIDA · PI VALENTE, SUSANA T · 2018 to 2020
$2.8M
Host factors regulating HIV latency and reactivationR37AI165137 · NIAID · UNIVERSITY OF FLORIDA · PI Susana T Valente · 2022 to 2026
$2.0M
Therapeutic Disruption of HIV Transcription by HIV-1 Tat Protein-Degrading MoleculesR01AI194820 · NIAID · UNIVERSITY OF FLORIDA · PI Susana T Valente · 2025 to 2026
$2.0M
Identification and characterization of chromatin regulators of HIV-1 latencyR33AI140439 · NIAID · UNIVERSITY OF FLORIDA · PI VALENTE, SUSANA T · 2021 to 2022
$1.8M
NIAIDNIAID NIH HHS R01 AI097012NIAID NIH HHS R01 AI167732NIAID NIH HHS R01 AI194820NIAID NIH HHS R33 AI140439NIAID NIH HHS R37 AI165137NIAID NIH HHS R61 AI140439NIAID NIH HHS UM1 AI164559NIH HHS R37 AI165137NIH HHS R61/R33 AI140439NIH HHS UM1AI164559
6 · The paper itself

Abstract

The chromatin landscape surrounding integrated HIV proviruses critically shapes viral transcription. We systematically examined ATP-dependent chromatin remodeling complexes (SWI/SNF, ISWI, CHD, and INO80) as regulators of HIV expression and identified the p400 complex, a member of the INO80 family, as a potent repressor. Depleting p400 subunits, including the EP400 ATPase and DMAP1, markedly increased HIV transcription and RNAPII elongation at the proviral locus. Mechanistically, EP400 associates with the RNAPII C-terminal domain, while DMAP1 directly engages the viral transactivator Tat, with repression requiring simultaneous interactions among EP400, DMAP1, and Tat. Loss of either EP400 or DMAP1 selectively increased infection and transcription of Tat-competent, but not Tat-deficient, viruses. Although p400 is recruited to active HIV chromatin via RNAPII in a Tat-independent manner, it restrains elongation once Tat accumulates during reactivation. DMAP1 binding to Tat's basic domain blocks Tat-TAR RNA interaction, thereby limiting p-TEFb-mediated RNAPII Ser2 phosphorylation and elongation. Thus, the p400 complex functions as a host restriction factor that limits Tat-dependent HIV transcription via a Tat-dependent proximal mechanism, highlighting the p400-Tat interface as a potential target for HIV cure strategies.

Indexed as

Chromatin Assembly and DisassemblyDNA-Binding ProteinsDNA HelicasesHIV-1tat Gene Products, Human Immunodeficiency VirusTranscription, GeneticATPases Associated with Diverse Cellular ActivitiesChromatinGene Expression Regulation, ViralHEK293 CellsHIV InfectionsHumansRNA Polymerase IITranscription FactorsATPases Associated with Diverse Cellular ActivitiesChromatinDNA-Binding ProteinsDNA HelicasesINO80 protein, humanRNA Polymerase IItat Gene Products, Human Immunodeficiency VirusTranscription Factors

Identifiers

PMID41414674
PMCPMC12714564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.